View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
NEMMERS JOSEPH M
(Last) (First) (Middle)
100 ABBOTT PARK ROAD
(Street)
ABBOTT PARK IL 60064-6400
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/15/2003 		3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value 39,901 D
Common shares without par value 10,274(1) I profit sharing trust
Common shares without par value 328(2) I by self for son
Common shares without par value 328(2) I by self for son
Common shares without par value 275(2) I by self for son
Common shares without par value 269(2) I by self for son
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)(3) 02/09/1999 02/08/2006 Common shares 6,358 21.85 D
Option (right to buy)(3) 02/14/2000 02/13/2007 Common shares 3,946 29.19 D
Option (right to buy)(3) 02/13/2000 02/12/2008 Common shares 4,070 37 D
Option (right to buy)(3) 02/13/2001 02/12/2008 Common shares 2,930 37 D
Option (right to buy)(3) 02/12/2001 02/11/2009 Common shares 4,885 45.22 D
Option (right to buy)(3) 02/12/2002 02/11/2009 Common shares 2,515 45.22 D
Option (right to buy)(3) 02/11/2003 02/10/2010 Common shares 2,881 34.7 D
Option (right to buy)(3) 02/09/2003 02/08/2011 Common shares 10,667 48.36 D
Option (right to buy)(3) 02/09/2004 02/08/2011 Common shares 5,333 48.36 D
Option (right to buy)(3) 12/03/2002 12/02/2011 Common shares 3,334 55.375 D
Option (right to buy)(3) 12/03/2003 12/02/2011 Common shares 3,333 55.375 D
Option (right to buy)(3) 12/03/2004 12/02/2011 Common shares 3,333 55.375 D
Option (right to buy)(3) 02/15/2003 02/14/2012 Common shares 13,334 57.06 D
Option (right to buy)(3) 02/15/2004 02/14/2012 Common shares 13,333 57.06 D
Option (right to buy)(3) 02/15/2005 02/14/2012 Common shares 13,333 57.06 D
Option (right to buy)(3) 10/25/2002 04/28/2004 Common shares 719 54.58 D
Option (right to buy)(3) 10/25/2002 04/27/2005 Common shares 1,863 54.58 D
Option (right to buy)(3) 10/25/2002 02/08/2006 Common shares 1,476 54.58 D
Option (right to buy)(3) 10/25/2002 02/13/2007 Common shares 2,980 54.58 D
Option (right to buy)(3) 10/25/2002 02/10/2010 Common shares 3,568 54.58 D
Option (right to buy)(3) 06/28/2003 06/27/2012 Common shares 6,500 38.73 D
Option (right to buy)(3) 06/28/2004 06/27/2012 Common shares 6,500 38.73 D
Option (right to buy)(3) 06/28/2005 06/27/2012 Common shares 6,500 38.73 D
Option (right to buy)(3) 06/03/2003 02/10/2010 Common shares 2,027 43.78 D
Option (right to buy)(3) 02/14/2004 02/13/2013 Common shares 20,000 35.36 D
Option (right to buy)(3) 02/14/2005 02/13/2013 Common shares 20,000 35.36 D
Option (right to buy)(3) 02/14/2006 02/13/2013 Common shares 20,000 35.36 D
Option (right to buy)(3) 12/01/2003 02/10/2010 Common shares 457 43.82 D
Explanation of Responses:
1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 19, 2003
2. Reporting person disclaims beneficial ownership of all securities held by his sons.
3. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement o ption feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
John A. Berry, Attorney-in-Fact for Joseph M. Nemmers 09/24/2003
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

 

POWER OF ATTORNEY

 

 

                The undersigned constitutes and appoints JOSE M. DE LASA, BRIAN J. SMITH, and JOHN A. BERRY, and each of them individually, as the undersigned’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for the undersigned and in the undersigned’s name, place and stead, to sign any and all Securities and Exchange Commission (“SEC”) statements of beneficial ownership of securities on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done under said Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

 

                A copy of this power of attorney shall be filed with the SEC.  The authorization set forth above shall continue in full force and effect until the undersigned revokes such authorization by written instructions to the attorney-in-fact.

 

 

 

Dated:  September 23, 2003

 

 

 

 

 

/s/ Joseph M. Nemmers

 

 

 

Signature of Reporting Person

 

 

 

Joseph M. Nemmers

 

 

 

Senior Vice President

 

 

 

Name and Title

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Abbott Laboratories

 

 

 

100 Abbott Park Road

 

 

 

Abbott Park, IL 60064-6400